Trademark Overview
On Tuesday, June 6, 2023, a trademark application was filed for MEDIPHARM LABS with the United States Patent and Trademark Office. The USPTO has given the MEDIPHARM LABS trademark a serial number of 98030022. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 10, 2023. This trademark is owned by MediPharm Labs Inc.. The MEDIPHARM LABS trademark is filed in the Chemical Products, Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Extraction, purification and processing of cannabis and its cannabinoid constituents for others in the nature of hemp and cannabidiol solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; processing of cannabis and its cannabinoid constituents in the nature of hemp and cannabidiol solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis into cannabis oil
Sale and distribution, namely, retail store services featuring extracted oil from cannabis for cosmetic purposes; exportation and importation agency in the field of dried medical cannabis, edible cannabis and extracted oil from cannabis; wholesale store services featuring cannabis oils and purified cannabis concentrates, active ingredients, distillates, and isolates for further processing into derivative products of non-medicated topicals and vape products containing cannabis for the cannabis industry; all the foregoing in the field of hemp or featuring products containing or for exclusive use with hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Unprocessed cannabis oils and purified cannabis concentrates, active chemical ingredients, distillates and isolates for use in the manufacture of derivative products in the nature of non-medicated topicals and vape products all containing or for exclusive use with hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Scientific laboratory services, namely, product formulation development of cannabis and its cannabinoid constituents in the nature of hemp and cannabidiol solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis into cannabis oil